4. Why?
o To make child health evidence
easier to find, interpret and use
o To “add value” to current
Cochrane reviews
o To increase impact of Cochrane
evidence for children
www.evidencebasedchildhealth.com
6. Editorial Board
o Virginia Moyer, Texas, USA
o Leontien Kremer, Amsterdam, NL
o Joan Robinson, Edmonton, Canada
o Jonathan Craig, Sydney, Australia
o Kent Stobart, Edmonton, Canada
o Lorne Becker, New York, USA
o Michael Smith, Craigavon, Northern Ireland
o Terry Klassen, Edmonton, Canada
o Martin Offringa, Amsterdam, NL
www.evidencebasedchildhealth.com
8. How? (cont…)
o Each issue:
n 46 Cochrane reviews, reprinted in full
o Expert commentary
o Table of key findings
o Summary
n Umbrella Review
n Tips and Tricks
n Editors’ Introduction
www.evidencebasedchildhealth.com
14. Journals Participating in the CSE Global Theme Issue on Poverty
and Human Development as of September 2006
Annals of African Medicine Nature Cell Biology
ATVB (Arteriosclerosis, Thrombosis, and Vascular Biology) Nature Genetics
BMJ Nature Immunology
Brazilian Journal of Medical and Biological Research Nature Materials
Breast Diseases: A Year Book Quarterly Nature Medicine
Canadian Pharmacists Journal Nature Methods
Circulation Nature Nanotechnology
Circulation Research Nature Physics
Clinics PLoS Biology
East African Medical Journal PLoS Clinical Trials
Environmental Health Perspectives PLoS Medicine
PNAS
Evidence Based Child Health *
Reviews of Modern Physics
Ghana Medical Journal
Science
Hypertension
Stroke
JAMA
The Lancet
Journal of Public Health Policy
Mountain Research and Development
Nature
www.evidencebasedchildhealth.com
15. EBCH Summary
o Aimed at health professionals
and consumers who wish a quick
overview of the review’s content
o Written by a writer at the Child
Health Field
o Peer reviewed by EB member
o example
www.evidencebasedchildhealth.com
21. Challenge: What to translate?
o ‘Demographics’
n Nr of RCTs, patients, contrasts?
n Quality SR?
n Quality RCTs?
o Contrasts, Outomes, and Subgroups
n Doses, routes, duration, delivered by whom?
n Clinical relevant, ELISAs, pain indexes?
n HQLQ trials?
o ‘Statistics’
n Patients ‘randomized’, or ‘analyzed’?
n Pooling heterogeneous material?
n Non pooled results?
www.evidencebasedchildhealth.com
40. Content challenges
o Expert commentaries
n Guidelines for experts
n Role of experts in a EB journal?
o Umbrella reviews and summaries
n Evolving format
n Implement and test Cochrane developments
o Tables of key findings
n Pooling of heterogenous data
n Selecting relevant outcomes
www.evidencebasedchildhealth.com
42. Processes – author/CRG
o The lead author of each review,
along with the CRG, are offered
the opportunity to review and
comment on the summary,
tables and commentary prior
to publication
o Review authors’ responses will
be published in EBCH, if desired
www.evidencebasedchildhealth.com
44. Relational challenges
o Review authors
n Duplicate publication?
n Can authors veto inclusion of their review?
o Cochrane Review Groups
n Extra work – for what reward?
n Conflict with module submission deadlines
o The Cochrane Collaboration
n Who owns Cochrane reviews?
www.evidencebasedchildhealth.com
46. Central question
o What value does EBCH add to
CLIB?
n Builds on work of the Collaboration
by making child health evidence
easier to find, interpret and use
n Translational steps involved
o We will ask our readership
n Is this the helpful format?
www.evidencebasedchildhealth.com